Item 2.02 Results of Operations and Financial Condition

On January 12, 2021, CytoSorbents Corporation (the "Company") issued a press release announcing preliminary, unaudited financial results for the fiscal year ended December 31, 2020. A copy of the press release is furnished herewith as Exhibit 99.1.*





 Item 9.01 Exhibits




(d) Exhibits

Exhibit No. Description


  99.1         CytoSorbents Corporation Press Release, dated January 12, 2021
104          Cover Page Interactive Data File (embedded with the Inline XBRL document)

* The information in Item 2.02 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

© Edgar Online, source Glimpses